NCT00778557View on ClinicalTrials.gov

Bioequivalence Study of Cefprozil 250 mg/ 5mL Powder For Oral Suspension Under Fasting Conditions

NACompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

June 30, 2005

Study Completion Date

July 31, 2005

Conditions
Healthy
Interventions
DRUG

CEFPROZIL FOR ORAL SUSPENSION USP 250 mg/ 5 mL

Trial Locations (1)

M1L 454

Biovail Contract Research, Toronto

All Listed Sponsors
lead

Ranbaxy Laboratories Limited

INDUSTRY

NCT00778557 - Bioequivalence Study of Cefprozil 250 mg/ 5mL Powder For Oral Suspension Under Fasting Conditions | Biotech Hunter | Biotech Hunter